Akademik Veri Yönetim Sistemi
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, cilt.21, ss.1309-1315, 2025 (SCI-Expanded, Scopus)
Purpose: Urinary incontinence (UI) is a common complication after radical prostatectomy (RP), adversely affecting patients' quality of life. This study aimed to evaluate the efficacy and safety of high-intensity focused electromagnetic (HIFEM) therapy as a noninvasive treatment for post-prostatectomy UI. Patients and Methods: Twenty-seven men (mean age f SD: 67.9 f 3.4 years) with persistent UI after RP underwent six HIFEM sessions (28 min, twice weekly) using the BTL EMSELLA (R) chair. Outcomes were assessed after the sixth session and at one-month follow-up. Primary endpoints were changes in International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) scores and daily pad use. Results: Baseline mean ICIQ-SF score was 10.58 f 4.15. This decreased to 5.43 f 3.85 after treatment and to 4.16 f 3.97 at one month, representing improvements of 53.1% and 60.6%, respectively (both p < 0.005). Daily pad use declined from baseline to 1.45 f 1.54 after treatment and 1.13 f 1.81 at follow-up (both p < 0.001). No adverse events were reported. Conclusion: HIFEM therapy significantly improved UI severity and reduced pad dependence in men with post-prostatectomy incontinence, with effects sustained for at least one month and no observed side effects. These findings support HIFEM as a safe, noninvasive treatment option warranting further study in larger, long-term trials.